Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Marilyn F. M. Johnston"'
Publikováno v:
American Journal of Clinical Pathology. 114:276-282
A survey of all licensed medical laboratories performing activated partial thromboplastin time (aPTT) testing in Canada was undertaken; the response rate was 50.7%. Preanalytic phase of testing seemed generally satisfactory, although 46% of laborator
Autor:
William S. Velasquez, Frank R. Dunphy, Paul J. Petruska, Gary Spitzer, Marilyn F. M. Johnston, Douglas Adkins
Publikováno v:
Transfusion. 37:737-748
Background Granulocyte-colony-stimulating factor (G-CSF) is a safe and effective agent for mobilization of neutrophils in normal donors, consistently resulting in cell yields per leukapheresis (LA) procedure that are superior to those with other agen
Publikováno v:
Bone Marrow Transplantation. 19:809-812
G-CSF administration to normal donors results in granulocyte apheresis yields generally greater than those observed with other neutrophil mobilizing agents. In vitro, neutrophils cultured with G-CSF exhibit prolonged survival; however, the random mig
Autor:
Thomas H. Price, Ronald A. Sacher, Lawrence T. Goodnough, William R. Vogler, Marilyn F. M. Johnston, Richard Hellman, Robert I. Abels, Douglas Bolgiano
Publikováno v:
The American Journal of Medicine. 101:22S-27S
The effects of therapy with recombinant human erythropoietin (Epoetin alfa) on erythropoiesis, preoperative autologous blood donation, and risk of exposure to allogeneic blood were evaluated in 204 patients scheduled to undergo elective orthopedic su
Autor:
Lawrence T. Goodnough, Marilyn F. M. Johnston, Robert I. Abels, William R. Vogler, Thomas H. Price, Douglas Bolgiano, Richard Hellman, Ronald A. Sacher
Publikováno v:
Transfusion. 36:29-36
This randomized controlled study was undertaken to determine the effect of recombinant human erythropoietin (rHuEPO) on erythropoiesis, autologous blood collection, and allogeneic transfusion risk in elective surgery patients with low baseline hemato
Autor:
Lawrence T. Goodnough, Robert I. Abels, D. Ciavarella, Mary Ellen Wissel, Thomas H. Price, Marilyn F. M. Johnston, William R. Vogler, Ronald A. Sacher, N. Khan, Kenneth D. Friedman
Publikováno v:
Transfusion. 34:66-71
BACKGROUND: Previous clinical trials have shown that the use of recombinant human erythropoietin (EPO) can facilitate autologous blood donation and reduce allogeneic blood transfusions in autologous blood donors who are anemic at first donation. Howe
Publikováno v:
Transfusion. 39:537-539
Autor:
Merlin H. Sayers, Les E. Silberstein, Kenneth C. Anderson, Roanne C. Rutman, Marilyn F. M. Johnston, Glenn Ramsey, Richard S. Eisenstadt, Lawrence T. Goodnough
Publikováno v:
The Annals of Thoracic Surgery. 50:675-683
We have reviewed the impact of evolving issues in coronary artery bypass grafting (CABG) on transfusion support for these patients. Issues include increased awareness of transfusion risks, reappraisal of traditional indicators triggering transfusion,
Publikováno v:
The International Journal of Cell Cloning. 10:146-148
To determine if peripheral blood cells (PBC) apheresed following mobilization with chemotherapy and recombinant growth factor further enhances hematopoietic recovery over that achieved with autologous bone marrow (ABM) and recombinant human granulocy
Publikováno v:
Journal of clinical apheresis. 13(2)
When selecting only leukocyte compatible donors, the requirement of ABO compatibility limits the investigation and application of granulocyte transfusion therapy by reducing the pool of potential donors. Ex vivo hetastarch (HES) sedimentation was eva